Company Description

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products.

Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property developed over more than a decade at the University of British Columbia and the BC Professional Firefighters Burn and Wound Healing Laboratory.

The Company's only device candidate is the CXU™ scaffold device candidate. The Company is conducting preclinical research and preparing for regulatory engagement to evaluate potential use in wound care and other medical applications.